Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OMNICELL, INC. Director's Dealing 2014

Feb 7, 2014

31980_dirs_2014-02-07_7cbd34d0-b5a8-494e-960f-13cff7418ccc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2014-02-04

Reporting Person: DREW J CHRISTOPHER (S.V.P., FIeld Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-04 Common Stock A 12500 Acquired 141320 Direct
2014-02-04 Common Stock A 25000 Acquired 166320 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-04 Stock Option (Right to Buy) $25.08 A 25000 Acquired 2024-02-03 Common Stock (25000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 128820 Direct
Common Stock 10504 Indirect

Footnotes

F1: Shares transferred to and held in trust for the benefit of Mr. Drew's family.

F2: Grant of restricted shares in consideration of services rendered. Shares shall vest semiannually over 48 months.

F3: The performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2015 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2015 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance.

F4: Shares vest ratably over 48 months, with a 1 year cliff.